Analyst Price Targets — KNSA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 10:25 am | — | Wells Fargo | $74.00 | $63.44 | TheFly | Kiniksa price target raised to $74 from $57 at Wells Fargo |
| June 29, 2026 11:53 am | — | Wedbush | $72.00 | $59.20 | TheFly | Kiniksa price target raised to $72 from $59 at Wedbush |
| April 29, 2026 11:42 am | — | Wedbush | $59.00 | $53.85 | TheFly | Kiniksa price target raised to $59 from $58 at Wedbush |
| April 28, 2026 5:03 pm | Roger Song | Jefferies | $71.00 | $53.80 | TheFly | Kiniksa price target raised to $71 from $58 at Jefferies |
| April 16, 2026 12:35 pm | — | Wedbush | $58.00 | $46.25 | TheFly | Kiniksa price target raised to $58 from $53 at Wedbush |
| February 19, 2026 10:35 am | — | Canaccord Genuity | $62.00 | $45.39 | TheFly | Kiniksa initiated with a Buy at Canaccord |
| January 13, 2026 1:42 pm | David Nierengarten | Wedbush | $50.00 | $39.65 | TheFly | Kiniksa price target raised to $50 from $48 at Wedbush |
| October 29, 2025 11:34 am | — | Goldman Sachs | $55.00 | $37.81 | TheFly | Kiniksa price target raised to $55 from $45 at Goldman Sachs |
| October 13, 2025 11:24 am | — | Wedbush | $44.00 | $37.89 | TheFly | Kiniksa price target raised to $44 from $38 at Wedbush |
| July 29, 2025 5:30 pm | — | Jefferies | $54.00 | $30.37 | TheFly | Kiniksa price target raised to $54 from $45 at Jefferies |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for KNSA

Let's take a look at four stocks, FLXS, ARKO, KNSA and BSET, with impressive net profit margins for a robust portfolio.

Kiniksa Pharmaceuticals International, plc (KNSA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Does Kiniksa Pharmaceuticals International, plc (KNSA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Kiniksa Pharmaceuticals International, plc (KNSA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Let's take a look at four stocks, BTSG, KNSA, ATI and VMI, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
